Halk Sağlığı ve Konjenital Hipotiroidi
Özet
Halk sağlığı çalışmalarında önemli bir yere sahip olan tiroid hastalıkları, özellikle hipotiroidizm tablosuyla bilişsel kapasiteyi olumsuz etkilediği için ayrı bir öneme sahiptir. Dünyada ve Türkiye'de iyot eksikliği ile konjenital hipotiroidi, sık görülmesi ve önlenebilir olması nedeniyle kritik bir sağlık sorunu olmayı sürdürmektedir. İyot eksikliği tedavi edilebilir olduğundan, erken müdahale edilmediğinde endemik guatrdan zekâ geriliğine kadar ciddi tablolara yol açmaktadır. Tarihsel süreçte binlerce yıl öncesine dayanan tiroid tedavileri, 1811'de iyotun keşfi ve ardından hormon izolasyonlarıyla modern döneme taşınmıştır. Dünya genelinde konjenital hipotiroidi prevalansı 1/3000 kabul edilmekle birlikte, Türkiye sıklığın yüksek olduğu bölgeler arasında yer almaktadır. Bu doğrultuda ülkemizde 2006 yılında başlatılan Neonatal Tarama Programı kapsamında, bebeklerin topuğundan alınan kan numuneleriyle erken teşhis ve tedavi protokolleri başarıyla uygulanmaktadır. Küresel düzeyde laboratuvar güvence programları ve tuzların zorunlu iyotlanması gibi önleme faaliyetleri yürütülse de az gelişmiş bölgelerde lojistik, finansman ve eğitim eksiklikleri nedeniyle tarama programlarında belirgin eşitsizlikler yaşanmaktadır.
Thyroid diseases hold a significant place in public health studies, with hypothyroidism conditions being particularly crucial as they directly reduce cognitive capacity. Iodine deficiency and congenital hypothyroidism remain critical global and national health concerns due to their high prevalence and preventable nature. Since iodine deficiency is fully treatable, early intervention can successfully prevent severe outcomes ranging from endemic goiter to mental retardation. The history of thyroid treatment dates back thousands of years, transitioning into modern medicine with the discovery of iodine in 1811 and subsequent thyroid hormone isolations. While the global prevalence of congenital hypothyroidism is estimated at 1/3000, Turkey is identified as a high-frequency region. Consequently, Turkey's Neonatal Screening Program, launched in 2006, utilizes heel prick blood samples to ensure timely diagnosis and treatment protocols. Although global preventative actions like quality assurance programs and mandatory salt iodization are widely implemented, significant disparities in screening coverage persist in underdeveloped regions due to challenges in logistics, funding, and public awareness.
Referanslar
Güler Ç, Akın L. Halk Sağlığı Temel Bilgiler. Hacettepe Üniversitesi Yayınları, Ankara 2006
WHO (2020). Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe. Available from: https://apps.who.int/iris/bitstream/handle/10665/330829/9789289054782-eng.pdf
Monaco F. Classification of thyroid diseases: Suggestions for a revision. J Clin Endocrinol Metab. 2003;88(4):1428–32.
Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.
World Health Organization, International Council for Control of Iodine Deficiency Disorders & United Nations Children's Fund (UNICEF). (1994). Indicators for assessing iodine deficiency disorders and their control through salt iodization. World Health Organization. https://apps.who.int/iris/handle/10665/70715
Milanesi A, Brent GA. Iodine and Thyroid Hormone Synthesis, Metabolism, and Action (2017). In: Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals.
Connolly, R. (1972). Iodbasedow: the response in an iodine deficient population to an increase in iodine consumption (Doctoral dissertation, University of Tasmania).
Menon K., Skeaff S.A. Iodine Deficiency Disorders (2016) In: The Encyclopedia of Food and Health.
World Health Organization. Nutrition Unit. (1996). Recommended iodine levels in salt and guidelines for monitoring their adequacy and effectiveness. World Health Organization. https://apps.who.int/iris/handle/10665/63322
Andersson M, Takkouche B, Egli I, et al. The WHO Global Database on iodine deficiency disorders: The importance of monitoring iodine nutrition. Scand J Nutr. 2003;47(4):162–166.
Li M, Eastman CJ. The changing epidemiology of iodine deficiency. Nat Rev Endocrinol. 2012;8:434-440.
Kopel J. A global perspective on newborn congenital hypothyroidism screening. Baylor Univ Med Cent Proc [Internet]. 2020;33(1):137-139. Available from: https://doi.org/10.1080/08998280.2019.1668715
Madariaga AG, Santos Palacios S, Guillén-Grima F, et al. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–31.
Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab. 2007;91(3):268–77.
Rastogi MV, Lafranchi SH. Congenital hypothyroidism Definition and classification. Orphanet J Rare Dis [Internet]. 2010;5(17):1–22. Available from: https://ojrd.biomedcentral.com/track/pdf/10.1186/1750-1172-5-17?site=ojrd.biomedcentral.com
Medda E, Olivieri A, Stazi MA, et al. Risk factors for congenital hypothyroidism: Results of a population case-control study (1997-2003). Eur J Endocrinol. 2005;153(6):765–73.
Karlsson B, Gustafsson J, Hedov G, et al. Thyroid dysfunction in Down’s syndrome: Relation to age and thyroid autoimmunity. Arch Dis Child. 1998;79(3):242–5.
Leoutsakos V. A short history of the thyroid gland. Hormones. 2004;3(4):268-271.
Leung AM, Braverman LE, Pearce EN. History of U.S. iodine fortification and supplementation. Nutrients. 2012;4(11):1740-1746.
Niazi AK, Kalra S, Irfan A, et al. Review Article Thyroidology over the ages. 2011;15.
Greenwald, I. (1960). Notes On The History Of Goitre In Sweden. Medical History, 4(3), 218-227. doi:10.1017/S0025727300025345
Aaronson S. A role for algae as human food in antiquity. Food Foodways. 1986;1(3):311-315.
Shuja A. History of thyroid surgery. Prof Med J. 2008;15(2):295-297.
Tanrıkulu, N. (2021). Ege yöresinde yetişen bazı önemli tıbbi bitkilerin kadim tıpta, halk tıbbında ve bugünkü araştırmalardaki yerinin karşılaştırmalı incelenmesi. (Yayınlanmamış yüksek lisans tezi). İstanbul Medipol Üniversitesi Sağlık Bilimleri Enstitüsü, İstanbul.
Bernet VJ. Thyroid hormone misuse and abuse. Endocrine. 2019;66(1):79–86.
Kaplan EL, Salti GI, Roncella M, et al. History of the Recurrent Laryngeal Nerve: From Galen to Lahey. World J Surg. 2008;33:386–393.
Lamberg BA. The thyroid gland in Anothomia Mundini (1316). Dan Med Arbog. 2001;142(7).
Leonardo on the human body. (1925). (Dover Fine Art, History of Art) Kindle Edition.
Segni M. Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence. 2017. In: Feingold KR, Anawalt B, Boyce A, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905261.
Kelly FC. Iodine in Medicine and Pharmacy Since its Discovery-1811-1961. Proceedings ofthe Royal Society ofMedicine. 1961;54:831-836.
Ahmed AM, Ahmed NH. History of disorders of thyroid. East Mediterr Heal J. 2005;11(3):459-469.
Parry, C. H. (1825). Collections from the Unpublished Medical Writings of the Late Caleb Hillier Parry. (Vol. 2). Underwoods.
Lindholm J, Laurberg P, Kocher T, et al. Hypothyroidism and Thyroid Substitution : Historical Aspects. J Thyroid Res. 2011;2011.
Eligar V, Taylor PN, Okosieme OE, et al. Thyroxine replacement: a clinical endocrinologist’s viewpoint. Assoc Clin Biochem Lab Med. 2016;53(4):421-433.
Hannan SA. The magnificent seven: a history of modern thyroid surgery. Int J Surgary. 2006;4(3):187-191.
Slater S. The discovery of thyroid replacement therapy. Part 3: A complete transformation. J R Soc Med. 2010;104:100-106.
Kendall EC. Iodine Compound in Thyroid. J Biol Chem [Internet]. 1919;39(1):125–47. Available from: http://dx.doi.org/10.1016/S0021-9258(18)87324-0
Kendall EC. The Isolation of Thyroxine and Cortisone : the Work of. J Biol Chem [Internet]. 2005;277(21):21–2. Available from: http://dx.doi.org/10.1016/S0021-9258(20)85219-3
Gross J & Pitt-Rivers R. The identification of 3: 5: 3'-L-triiodothyronine in human plasma. The Lancet.1952;259(6705), 439-441.
McAninch EA & Bianco AC. The History and Future of Treatment of Hypothyroidism. Ann Intern Med. 2016;164(1):50-56.
Jackson IM, Cobb WE. Why does anyone still use desiccated thyroid USP? Am J Med. 1978;64(2):284-248.
Dussault J, Row VV, Lickrish G, et al. Studies of serum triiodothyronine concentration in maternal and cord blood: transfer of triiodothyronine across the human placenta. J Clin Endocrinol Metab. 1969;29(4):595–603.
Guthrie R & Susi A. A Simple Phenylalanine Method For Detecting Phenylketonuria In Large Populatıons Of Newborn Infants. Pediatrics. 1963;32:338.
Gonzalez J & Willis MS. Robert Guthrie, MD, PhD: clinical chemistry/microbiology. Laboratory Medicine. 2009;40(12), 748-749.
Wilson JMG, Jungner G & WHO. Principles and practice of screening for disease. Geneva, Switzerland: Wold Health Organization. Public Health Pap. 1968
Utiger RD. Radioimmunoassay of Human Plasma Thyrotropin. J Clin Invest. 1965;44(8):1277-1286.
Chopra IJ, Solomon DH, Ho RS. A Radioimmunoassay Of Thyroxıne. J Clin Endocrinol Metab. 1971;33(5):865-868.
Chopra IJ, Solomon DH, Beall GN. Radioimmunassay for measurement of triiodothyronine in human serum. J Clin Invest. 1971;50(10):2033-2041.
Dussault JH. The Anecdotal History of Screening for Congenital Hypothyroidism. 1999;84(12):4332–4.
Jacobsen BB, Brandt NJ. Congenital hypothyroidism in Denmark. Arch Dis Child. 1981;56(2):134-136.
Raiti S, Newns GH. Cretinism: Early Diagnosis and its Relation to Mental Prognosis. 1971;(March):692-694.
Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital bypothyroidism treated before age three months. J Pediatr. 1972;81(5):912–5.
Walfish PG. Evaluation of three thyroid-function screening tests for detecting neonatal hypothyroidism. Lancet. 1976;5(1):1208-1210.
Glorieux J, Desjardins M, Letarte J, et al. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res. 1988;24(1):6–8.
Hardy JD, Zayed R, Doss I, et al. Cord blood thyroxine and thyroid stimulating hormone screening for congenital hypothyroidism: how useful are they? J Pediatr Endocrinol Metab. 2008;21(3):245-249.
Dussault JH & Morissette J. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: a myth? J Clin Endocrinol Metab. 1983;56(4):849-852.
Shapira SK, Hinton CF, Held PK, et al. Single newborn screen or routine second screening for primary congenital hypothyroidism. Physiol Behav. 2015;116(3):125-132.
Coody D, Yetman RJ, Montgomery D, et al. Early hospital discharge and the timing of newborn metabolic screening. Clin Pediatr. 1993;32(8):463-436.
Rose SR, Brown RS, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117(6):2290-2303.
Kayton A. Newborn Screening: A Literature Review. Neonatal Netw. 2018;26(2):85–95.
De Jesús VR, Mei JV, Cordovado SK, et al. The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality. Int J Neonatal Screen. 2016;1(1):13–26.
Centers for Disease Control and Prevention National Center for Environmental Health. (2020) Newborn Screening Quality Assurance Program 2020 Annual Summary Report, Volume 38. Available from: https://www.cdc.gov/labstandards/pdf/nsqap/NSQAP_Annual_Summary_2020-508.pdf
Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pr Res Clin Endocrinol Metab. 2014;28(2):175-187.
Koracin V, Mlinaric M, Baric I, et al. Current Status of Newborn Screening in Southeastern Europe. Frontiers in pediatrics, 2021;9: 391.
Hettiarachchi M, Liyanage C, Liyanarachchi N. Screening newborns for congenital hypothyroidism. Guidance for developing programmes. International Atomic Energy Agency publication. 2005;54(1).
Cinaz P, Yeşilkaya E, Acar D, ve ark. Yenidoğan Konjenital Hipotiroidizm Tarama Sonuçlarının Değerlendirilmesi. İstanbul Tıp Fakültesi Derg. 2008;71(3):78-83.
Yordam N, Çalikoĝlu AS, Hatun Ş, et al. Screening for congenital hypothyroidism in Turkey. Eur J Pediatr. 1995;154:614–6.
Büyükgebiz A, Ören H, Eroğlu Y, ve ark. İzmir’de Konjenital Hipotiroidi Taraması. Endokrinol Ulus Derg. 1994;4:113–7.
Simsek E, Karabay M, Kocabay K. Neonatal screening for congenital hypothyroidism in West Black Sea area, Turkey. Int J Clin Pr. 2005;59(3):336–41.
Sağlam H, Büyükuysal L, Köksal N, et al. Increased incidence of congenital hypothyroidism due to iodine deficiency. Pediatr Int. 2007;49(1):76–9.
Kuşdal Y, Mutlu Yeşiltepe G, Özsu E, et al. Congenital hypothyroidism screening program in Turkey: a local evaluation. Turk J Pediatr. 2012;54(6):590–5.
Dilli D, Özbaş S, Acıcan D, et al. Newborn Screening Programme for Congenital Hypothyroidism in Turkey. J Clin Res Pediatr Endocrinol. 2013;5(2):73–9.
Aytaç N, Yüzügüllü DATA, Gönültaş T, ve ark. Adana İli 2010-2011 Yılları Yenidoğan Tarama Sonuçları İle Fenilketonüri, Konjenital Hipotiroidi ve Biyotinidaz Eksikliği Tanısı Alanların Değerlendirilmesi. Sağlık ve Toplum. 2016;26(3):37–43.
T.C. Resmi Gazete. Neonatal Tarama Programı Genelgesi. 19/12/2006, Sayı: 4911, Başbakanlık Basımevi, Ankara.
T.C. Sağlık Bakalnlığı Halk Sağlığı Genel Müdürülüğü. Yenidoğan Metabolik Ve Endokrin Tarama Programı. (12.12.2021 tarihinde https://hsgm.saglik.gov.tr/depo/birimler/cocuk_ergen_db/dokumanlar/ces_materyal/saglik_personeli_egitim/NTP_Saglik_Personeli.pdf adresinden ulaşılmıştır).
Carney LA, Quinlan JD, West JM. Thyroid disease in pregnancy. Clin Endocrinol Metab. 2014;89(4):273–8.
Lazarus J, Brown RS, Daumerie C, et al. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur Thyroid J. 2014;3(2):76–94.
Zantour, B., Alaya, W., Marmouch, H., et al. (2013). Hypothyroidism in pregnancy. Current topics in hypothyroidism with focus on development. Rijeka, Croatia: In Tech, 29-62.
Glinoer D. Feto-maternal repercussions of iodine deficiency during pregnancy. An update. Ann Endocrinol. 2003;64(1):37–44.
Ladenson, P. W., Singer, P. A., Ain, K. B., et al. (2000). American Thyroid Association guidelines for detection of thyroid dysfunction. Archives of internal medicine, 160(11), 1573-1575.
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081–125.
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid. 2017;27(3):315–89.
Baskin HJ, Duick DS, Guttler RB, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocrine practice, 2002;8(6):457-469.
Lazarus JH, Bestwick JP, Channon S, et al. Antenatal Thyroid Screening and Childhood Cognitive Function. N Engl J Med. 2012;366(6):493–501.
Hales C, Taylor PN, Channon S, et al. Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Cognition. J Clin Endocrinol Metab. 2018;103(4):1583–91.
Türkiye Endokrinoloji ve Metabolizma Derneği (2017). Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu 2017, Ankara: Türkiye Klinikleri.
Özon A, Tekin N, Şıklar Z, ve ark. Gebelikte tiroid hastalıklarının neonatal etkileri ve TSH yüksekliği olan bebeğe yaklaşım: Türk Neonatoloji ve Çocuk Endokrinoloji ve Diyabet Dernekleri uzlaşı raporu. Türk Pediatri Arş. 2018; 53: 209-223
Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: Where do we stand in 2013? THYROID. 2013;23(5):523-528.
Bhutta ZA. Prevention of Micronutrient Deficiencies: Tools for Policy Makers and Public Health Workers. Vol. 317, Bmj. 1998;317:1460.
WHO. (2013) Urinari iodine concentrations for determining iodine status in populations [Internet]. Geneva. Available from: http://apps.who.int/iris/bitstream/10665/85972/1/WHO_NMH_NHD_EPG_13.1_eng.pdf
Zimmermann MB, Andersson M. Global perspectives in endocrinology: Coverage of iodized salt programs and iodine status in 2020. Eur J Endocrinol. 2021;185(1):13–21.
UNICEF.(2008) Sustainable Elimination of Iodine Deficiency Progress since the 1990 World Summit for Children. New York, USA
UNICEF, GAIN. (2018) BRIGHTER FUTURES Protecting early brain development through salt iodization [Internet]. Available from: https://www.unicef.org/nutrition/files/brighter-future_Protecting-early-brain-development-through-salt-iodization-web-final.pdf
UNICEF. Iodine. 25.12.2021 tarihinde https://data.unicef.org/topic/nutrition/iodine/. adresinden ulaşılmıştır).
Türkiye Nüfus ve Sağlık Araştırması (TNSA), 2008. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü, Ankara, Türkiye. http://www.hips.hacettepe.edu.tr/ Erişim:13.01.2022.
T.C. Resmi Gazete. Gıda Maddelerinin Ve Umumi Sağlığı İlgilendiren Eşya Ve Levazımın Hususi Vasıflarını Gösteren Tüzük. 18/10/1952, No : 8236, Başbakanlık Basımevi, Ankara.
T.C. Sağlık Bakanlığı. İyot Haftası Genelgesi. 29.04.2005. Sayı:72
T.C. Resmi Gazete. Türk Gıda Kodeksi Yemeklik Tuz Tebliği. 09.07.1998. Sayı:23397, Başbakanlık Basımevi, Ankara.
Tarım ve Köyişleri Bakanlığı. Türk Gıda Kodeksi Yemeklik Tuz Tebliği’nde Değişiklik Yapılması Hakkında Tebliğ. 2000.
T.C. Resmi Gazete. Türk Gıda Kodeksi Tuz Tebliği. 16.08.2013. Sayı: 28737, Başbakanlık Basımevi, Ankara.
Visser TJ, Fagin JA, Abalovich M, et al. May 25 th is World Thyroid Day ! Press annoucement. Commentary, 2008.
T.C. Sağlık Bakanlığı (2019). Erkişkin Bazı Metabolizma Hastalıkları (Tiroid, Osteoporoz, Gut) ve Çölyak Hastalığı Kontrol Programı 2019-2023. Çakır B, Özdemir D. (Ed.) Ankara
